Literature DB >> 5645966

The importance of circulating cancer cells in patients with hypernephroma.

J C Gazet, B Phillips.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5645966      PMCID: PMC1902288     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  11 in total

Review 1.  RECENT ADVANCES IN MEDICINE AND SURGERY. RENAL CELL CANCER. 3. TYPES OF TREATMENT.

Authors:  H GRABSTALD
Journal:  N Y State J Med       Date:  1964-11-15

2.  EXPERIMENTAL USE OF ANTI-CANCER AGENTS IN THE PERITONEAL CAVITY.

Authors:  B MCKIBBIN; J C GAZET
Journal:  Br J Surg       Date:  1964-09       Impact factor: 6.939

3.  EXPERIMENTAL USE OF ANTICANCER COMPOUNDS IN THE CONTROL OF INTRAPERITONEAL MALIGNANT DISEASE.

Authors:  B MCKIBBIN; J GAZET; E HOPPE
Journal:  Surg Forum       Date:  1963

4.  BLOOD VOLUME.

Authors:  P D GRIFFITHS; R G HUNTSMAN; C G THOMAS
Journal:  Br Med J       Date:  1964-01-04

5.  The prognostic value of tumor cells in the blood.

Authors:  A L WATNE; A A SANDBERG; G E MOORE
Journal:  Arch Surg       Date:  1961-08

6.  A vesical calculus containing methylene blue.

Authors:  G A MISSEN
Journal:  Br J Surg       Date:  1960-03       Impact factor: 6.939

7.  Cancer cells in blood. Results of a simplified isolation technique.

Authors:  L LONG; O JONASSON; S ROBERTS; R MCGRATH; E MCGREW; W H COLE
Journal:  Arch Surg       Date:  1960-06

8.  Cancer cells in the circulating blood.

Authors:  S S ROBERTS; A L WATNE; E A McGREW; R G McGRATH; S NANOS; W H COLE
Journal:  Surg Forum       Date:  1957

9.  Factors in the prognosis of carcinoma of the kidney.

Authors:  E W RICHES
Journal:  J Urol       Date:  1958-02       Impact factor: 7.450

10.  New growths of the kidney and ureter.

Authors:  E W RICHES; I H GRIFFITHS; A C THACKRAY
Journal:  Br J Urol       Date:  1951-12
View more
  1 in total

1.  On the significance of lymphoid cell infiltration in hypernephromas.

Authors:  E Kiely; M Greally; J Greally
Journal:  Ir J Med Sci       Date:  1972 Jul-Sep       Impact factor: 1.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.